Immunomodulatory nanomedicine for osteoporosis: Current practices and emerging prospects

Yankun Luo1, Hanghang Liu1, Ming Chen2

  • 1State Key Laboratory of Oral Diseases & National Center for Stomatology& National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.

Acta Biomaterialia
|March 17, 2024
PubMed

Insights

Immunomodulatory nanomedicine offers a promising alternative for osteoporosis treatment, overcoming limitations of traditional drugs. This approach enhances bone formation and reduces adverse effects for improved osteoporosis therapy.

Area of Science:

  • Osteoimmunology and Nanomedicine
  • Biomaterials Science
  • Skeletal Biology

Background:

  • Osteoporosis disrupts bone remodeling, necessitating novel treatments beyond conventional drugs with adverse effects.
  • Current therapies for osteoporosis face limitations in efficacy and safety, driving the search for advanced strategies.
  • Understanding osteoimmunology and osteogenic-angiogenic coupling is crucial for developing effective osteoporosis treatments.

Purpose of the Study:

  • To review the application of immunomodulatory nanomedicine in treating osteoporosis.
  • To analyze the integration of nanomaterials with carrier biomaterials for enhanced osteoporosis therapy.
  • To discuss emerging strategies and future directions in nanomedicine for osteoporosis.

Main Methods:

  • Literature review of immunomodulatory nanomedicine applications in osteoporosis.
  • Analysis of nanomaterial types and their integration with biomaterials.
  • Exploration of osteoimmunology and osteogenesis-angiogenesis coupling principles.

Main Results:

  • Immunomodulatory nanomedicines show potential for minimal adverse reactions and enhanced bone induction in osteoporosis.
  • Nanomaterials offer improved osteogenic activity and therapeutic effects compared to traditional osteoporosis treatments.
  • The integration of nanomedicine and immunomodulation presents a promising avenue for osteoporosis management.

Conclusions:

  • Immunomodulatory nanomedicine represents a significant advancement in osteoporosis treatment, offering improved efficacy and safety.
  • Further research into emerging strategies within immunomodulatory nanomedicine is warranted for osteoporosis therapy.
  • This review provides a comprehensive overview of nanomedicine's role in combating osteoporosis, guiding future research and clinical applications.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K